Nilotinib treatment‐associated cerebrovascular disease and stroke

Saved in:
Bibliographic Details
Published in:American journal of hematology 2013-06, Vol.88 (6), p.534-535
Main Authors: Coon, Elizabeth A., Zalewski, Nicholas L., Hoffman, Ernest Matthew, Tefferi, Ayalew, Flemming, Kelly D.
Format: Article
Language:English
Subjects:
Aged
Cerebrovascular Disorders - chemically induced
Female
Hematology
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy
Pyrimidines - administration & dosage
Pyrimidines - adverse effects
Stroke - chemically induced
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4212-692c005d8fe3d478aea842bc53a696ca740d9c0eaa43bb8db0cfc3766c1c72073
cites cdi_FETCH-LOGICAL-c4212-692c005d8fe3d478aea842bc53a696ca740d9c0eaa43bb8db0cfc3766c1c72073
container_end_page 535
container_issue 6
container_start_page 534
container_title American journal of hematology
container_volume 88
creator Coon, Elizabeth A.
Zalewski, Nicholas L.
Hoffman, Ernest Matthew
Tefferi, Ayalew
Flemming, Kelly D.
description
doi_str_mv 10.1002/ajh.23442
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1353418489</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2975833091</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4212-692c005d8fe3d478aea842bc53a696ca740d9c0eaa43bb8db0cfc3766c1c72073</originalsourceid><addsrcrecordid>eNp1kL1OwzAURi0EoqUw8AIoEhND2uufOM5YVUBBFSwwWze2I1LSptgJqBuPwDPyJARS2JjuHY7OJx1CTimMKQCb4PJpzLgQbI8MKWQyVjJh-2QIXNLuh2xAjkJYAlAqFBySAeMJkyJLhmR2V1Z1U67LPGq8w2bl1s3n-weGUJsSG2cj47zLff2KwbQV-siWwWFwEa5tFBpfP7tjclBgFdzJ7o7I49Xlw2weL-6vb2bTRWwEoyyWGTMAiVWF41akCh0qwXKTcJSZNJgKsJkBhyh4niubgykMT6U01KQMUj4i57134-uX1oVGL-vWr7tJTXnCBVVCZR110VPG1yF4V-iNL1fot5qC_s6lu1z6J1fHnu2Mbb5y9o_87dMBkx54Kyu3_d-kp7fzXvkFKop1Kw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1353418489</pqid></control><display><type>article</type><title>Nilotinib treatment‐associated cerebrovascular disease and stroke</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Coon, Elizabeth A. ; Zalewski, Nicholas L. ; Hoffman, Ernest Matthew ; Tefferi, Ayalew ; Flemming, Kelly D.</creator><creatorcontrib>Coon, Elizabeth A. ; Zalewski, Nicholas L. ; Hoffman, Ernest Matthew ; Tefferi, Ayalew ; Flemming, Kelly D.</creatorcontrib><identifier>ISSN: 0361-8609</identifier><identifier>EISSN: 1096-8652</identifier><identifier>DOI: 10.1002/ajh.23442</identifier><identifier>PMID: 23526495</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Aged ; Cerebrovascular Disorders - chemically induced ; Female ; Hematology ; Humans ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy ; Pyrimidines - administration &amp; dosage ; Pyrimidines - adverse effects ; Stroke - chemically induced</subject><ispartof>American journal of hematology, 2013-06, Vol.88 (6), p.534-535</ispartof><rights>Copyright © 2013 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4212-692c005d8fe3d478aea842bc53a696ca740d9c0eaa43bb8db0cfc3766c1c72073</citedby><cites>FETCH-LOGICAL-c4212-692c005d8fe3d478aea842bc53a696ca740d9c0eaa43bb8db0cfc3766c1c72073</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23526495$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Coon, Elizabeth A.</creatorcontrib><creatorcontrib>Zalewski, Nicholas L.</creatorcontrib><creatorcontrib>Hoffman, Ernest Matthew</creatorcontrib><creatorcontrib>Tefferi, Ayalew</creatorcontrib><creatorcontrib>Flemming, Kelly D.</creatorcontrib><title>Nilotinib treatment‐associated cerebrovascular disease and stroke</title><title>American journal of hematology</title><addtitle>Am J Hematol</addtitle><subject>Aged</subject><subject>Cerebrovascular Disorders - chemically induced</subject><subject>Female</subject><subject>Hematology</subject><subject>Humans</subject><subject>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy</subject><subject>Pyrimidines - administration &amp; dosage</subject><subject>Pyrimidines - adverse effects</subject><subject>Stroke - chemically induced</subject><issn>0361-8609</issn><issn>1096-8652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNp1kL1OwzAURi0EoqUw8AIoEhND2uufOM5YVUBBFSwwWze2I1LSptgJqBuPwDPyJARS2JjuHY7OJx1CTimMKQCb4PJpzLgQbI8MKWQyVjJh-2QIXNLuh2xAjkJYAlAqFBySAeMJkyJLhmR2V1Z1U67LPGq8w2bl1s3n-weGUJsSG2cj47zLff2KwbQV-siWwWFwEa5tFBpfP7tjclBgFdzJ7o7I49Xlw2weL-6vb2bTRWwEoyyWGTMAiVWF41akCh0qwXKTcJSZNJgKsJkBhyh4niubgykMT6U01KQMUj4i57134-uX1oVGL-vWr7tJTXnCBVVCZR110VPG1yF4V-iNL1fot5qC_s6lu1z6J1fHnu2Mbb5y9o_87dMBkx54Kyu3_d-kp7fzXvkFKop1Kw</recordid><startdate>201306</startdate><enddate>201306</enddate><creator>Coon, Elizabeth A.</creator><creator>Zalewski, Nicholas L.</creator><creator>Hoffman, Ernest Matthew</creator><creator>Tefferi, Ayalew</creator><creator>Flemming, Kelly D.</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope></search><sort><creationdate>201306</creationdate><title>Nilotinib treatment‐associated cerebrovascular disease and stroke</title><author>Coon, Elizabeth A. ; Zalewski, Nicholas L. ; Hoffman, Ernest Matthew ; Tefferi, Ayalew ; Flemming, Kelly D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4212-692c005d8fe3d478aea842bc53a696ca740d9c0eaa43bb8db0cfc3766c1c72073</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Aged</topic><topic>Cerebrovascular Disorders - chemically induced</topic><topic>Female</topic><topic>Hematology</topic><topic>Humans</topic><topic>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy</topic><topic>Pyrimidines - administration &amp; dosage</topic><topic>Pyrimidines - adverse effects</topic><topic>Stroke - chemically induced</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Coon, Elizabeth A.</creatorcontrib><creatorcontrib>Zalewski, Nicholas L.</creatorcontrib><creatorcontrib>Hoffman, Ernest Matthew</creatorcontrib><creatorcontrib>Tefferi, Ayalew</creatorcontrib><creatorcontrib>Flemming, Kelly D.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><jtitle>American journal of hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Coon, Elizabeth A.</au><au>Zalewski, Nicholas L.</au><au>Hoffman, Ernest Matthew</au><au>Tefferi, Ayalew</au><au>Flemming, Kelly D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nilotinib treatment‐associated cerebrovascular disease and stroke</atitle><jtitle>American journal of hematology</jtitle><addtitle>Am J Hematol</addtitle><date>2013-06</date><risdate>2013</risdate><volume>88</volume><issue>6</issue><spage>534</spage><epage>535</epage><pages>534-535</pages><issn>0361-8609</issn><eissn>1096-8652</eissn><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>23526495</pmid><doi>10.1002/ajh.23442</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0361-8609
ispartof American journal of hematology, 2013-06, Vol.88 (6), p.534-535
issn 0361-8609
1096-8652
language eng
recordid cdi_proquest_journals_1353418489
source Wiley-Blackwell Read & Publish Collection
subjects Aged
Cerebrovascular Disorders - chemically induced
Female
Hematology
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy
Pyrimidines - administration & dosage
Pyrimidines - adverse effects
Stroke - chemically induced
title Nilotinib treatment‐associated cerebrovascular disease and stroke
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T02%3A47%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nilotinib%20treatment%E2%80%90associated%20cerebrovascular%20disease%20and%20stroke&rft.jtitle=American%20journal%20of%20hematology&rft.au=Coon,%20Elizabeth%20A.&rft.date=2013-06&rft.volume=88&rft.issue=6&rft.spage=534&rft.epage=535&rft.pages=534-535&rft.issn=0361-8609&rft.eissn=1096-8652&rft_id=info:doi/10.1002/ajh.23442&rft_dat=%3Cproquest_cross%3E2975833091%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4212-692c005d8fe3d478aea842bc53a696ca740d9c0eaa43bb8db0cfc3766c1c72073%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1353418489&rft_id=info:pmid/23526495&rfr_iscdi=true